| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/026988110001400410 |
| P698 | PubMed publication ID | 11198060 |
| P2093 | author name string | N R Dunn | |
| G L Pearce | |||
| S A Shakir | |||
| P2860 | cites work | Convulsions induced by donepezil | Q28343204 |
| Donepezil therapy in clinical practice: a randomized crossover study | Q33145215 | ||
| Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study | Q33813170 | ||
| A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group | Q34744744 | ||
| Tacrine. A cause of fatal hepatotoxicity? | Q53221544 | ||
| The effects of donepezil in Alzheimer's disease - results from a multinational trial. | Q53228615 | ||
| Donepezil overdose: a tenfold dosing error. | Q53230200 | ||
| Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology. | Q53333243 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 406-408 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Journal of Psychopharmacology | Q6295819 |
| P1476 | title | Adverse effects associated with the use of donepezil in general practice in England | |
| P478 | volume | 14 |
| Q33165693 | A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence |
| Q46391646 | Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial |
| Q41436212 | Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase. |
| Q50952255 | Anti-inflammatory, antioxidant and anti-acetylcholinesterase activities of Bouvardia ternifolia: potential implications in Alzheimer's disease. |
| Q33155710 | Cardiovascular effects of cholinesterase inhibitors in Alzheimer's disease |
| Q44273880 | Chlorpyrifos shares stimulus properties with pentylenetetrazol as evaluated by an operant drug discrimination task. |
| Q44407158 | Cognitive Enhancing Properties and Tolerability of Cholinergic Agents in Mice: A Comparative Study of Nicotine, Donepezil, and SIB-1553A, a Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors |
| Q33154076 | Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil |
| Q34965949 | Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics |
| Q85523070 | Donepezil induced antecollis in a patient with Parkinson's disease dementia |
| Q37282357 | Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats. |
| Q41179447 | Effectiveness of rivastigmine on positive, negative, and cognitive symptoms of schizophrenia: a double-blind clinical trial |
| Q55082462 | Effects of Dorema ammoniacum Gum on Neuronal Epileptiform Activity-Induced by Pentylenetetrazole. |
| Q33980960 | Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's disease |
| Q92136293 | Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson's disease |
| Q99605606 | Evaluation of the Adverse Effects of Chronic Exposure to Donepezil (An Acetylcholinesterase Inhibitor) in Adult Zebrafish by Behavioral and Biochemical Assessments |
| Q33274853 | Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysis |
| Q35891535 | Long-term cholinesterase inhibitor treatment of Alzheimer's disease. |
| Q51954000 | Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. |
| Q36244982 | Models and mechanisms of vascular dementia |
| Q43151006 | Nantenine as an acetylcholinesterase inhibitor: SAR, enzyme kinetics and molecular modeling investigations. |
| Q77399415 | Pharmacoepidemiology and drug safety |
| Q46899917 | Protective effect of donepezil on retinal ganglion cells in vitro and in vivo |
| Q36169462 | Role of donepezil in autism: its conduciveness in psychopharmacotherapy |
| Q34070798 | Seizures and epilepsy in Alzheimer's disease |
| Q35839178 | Sleep disorders in Alzheimer's disease and other dementias |
| Q33165044 | Syncope secondary to second-degree atrioventricular block with donepezil use |
| Q36622649 | The significance of the cholinergic system in the brain during aging and in Alzheimer's disease |
Search more.